Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN2 | P17706 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.38 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18243710 | 0.89 | PTPN2 (0.36) | PTPN2PTPN1PTPN6PTPN11KCNH2 | |
| SCHEMBL18377981 | 0.88 | TAAR1 (0.33) | PTPN2PTPN1PTPN6PTPN11TAAR1 | |
| SCHEMBL18242937 | 0.87 | PTPN2 (0.35) | PTPN2PTPN1PTPN6PTPN11KCNH2 | |
| SCHEMBL18242341 | 0.83 | TSHR (0.37) | PTPN2PTPN1PTPN6PTPN11KCNH2 | |
| SCHEMBL18242918 | 0.80 | PTPN2 (0.42) | PTPN2PTPN1PTPN6PTPN11KCNH2 | |
| SCHEMBL18242499 | 0.79 | TSHR (0.30) | — | |
| SCHEMBL18242806 | 0.78 | PTPN2 (0.44) | PTPN2PTPN1PTPN6PTPN11KCNH2 | |
| SCHEMBL18242088 | 0.78 | TAAR1 (0.39) | KCNH2TAAR1SIGMAR1HDAC1HDAC8 | |
| SCHEMBL18243026 | 0.76 | TAAR1 (0.31) | PTPN2PTPN1PTPN6PTPN11TAAR1 | |
| SCHEMBL18242500 | 0.75 | PTPN2 (0.36) | PTPN2PTPN1PTPN6PTPN11TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | PTPN2 3244/4885PTPN1 3116/4885PTPN6 3525/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | PTPN2 3244/4885PTPN1 3116/4885PTPN6 3525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.